Barclays Maintains Underweight on Allstate, Lowers Price Target to $221

Benzinga Newsdesk www.benzinga.com Negative 91.3%

Neg 91.3% Neu 0% Pos 0%

Barclays analyst Alex Scott maintains Allstate (NYSE:ALL) with a Underweight and lowers the price target from $226 to $221.